UnitedHealth raises full-year EPS guidance to $20 despite stagnant revenue growth, as the insurer relies on pricing power to combat commercial medical cost trends exceeding 11%.
UnitedHealth raised its full-year adjusted EPS guidance to $19.50-$20.00 and reported a 55% increase in operating earnings, but revenue growth stalled and commercial medical cost trend remains above 11%.
UnitedHealth Group reported a 55% surge in second-quarter operating earnings to $8 billion, prompting management to raise its full-year adjusted EPS guidance to $19.50-$20.00. Despite the earnings beat, revenue growth has stalled at 0.4%, shifting the company's focus toward margin expansion and aggressive repricing strategies to offset persistent medical cost trends exceeding 11% in commercial plans.
Revenue growth has slowed to 0.4% due to a combination of shrinking Medicare Advantage enrollment and a strategic shift toward repricing existing contracts rather than pursuing volume-based expansion.
Management identifies the arbitration process under the No Surprises Act as a key driver, noting that payouts to out-of-network providers are currently averaging 11 times the rates paid by Medicare.